PDB Short entry for 4F0E HEADER TRANSFERASE/TRANSFERASE INHIBITOR 04-MAY-12 4F0E TITLE HUMAN ADP-RIBOSYLTRANSFERASE 7 (ARTD7/PARP15), CATALYTIC DOMAIN IN TITLE 2 COMPLEX WITH STO1102 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 15; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: PARP-15, B-AGGRESSIVE LYMPHOMA PROTEIN 3; COMPND 5 EC: 2.4.2.30; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BAL3, PARP15; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)R3 PRARE; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS ARTD, PARP, POLY (ADP-RIBOSE) POLYMERASE, ADP-RIBOSE, BAL3, B- KEYWDS 2 AGGRESSIVE LYMPHOMA PROTEIN 3, TRANSFERASE, GLYCOSYLTRANSFERASE, KEYWDS 3 NUCLEUS, TRANSCRIPTION, TRANSCRIPTION REGULATION, TRANSFERASE- KEYWDS 4 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,C.D.ANDERSSON,A.LINDGREN,A.G.THORSELL,T.EKBLAD,S.SPJUT, AUTHOR 2 J.WEIGELT,M.ELOFSSON,A.LINUSSON,H.SCHULER REVDAT 3 13-SEP-23 4F0E 1 REMARK SEQADV REVDAT 2 31-OCT-12 4F0E 1 JRNL REVDAT 1 05-SEP-12 4F0E 0 JRNL AUTH C.D.ANDERSSON,T.KARLBERG,T.EKBLAD,A.E.LINDGREN,A.G.THORSELL, JRNL AUTH 2 S.SPJUT,U.UCIECHOWSKA,M.S.NIEMIEC,P.WITTUNG-STAFSHEDE, JRNL AUTH 3 J.WEIGELT,M.ELOFSSON,H.SCHULER,A.LINUSSON JRNL TITL DISCOVERY OF LIGANDS FOR ADP-RIBOSYLTRANSFERASES VIA JRNL TITL 2 DOCKING-BASED VIRTUAL SCREENING. JRNL REF J.MED.CHEM. V. 55 7706 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22823910 JRNL DOI 10.1021/JM300746D REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7_650) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 30110 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.710 REMARK 3 FREE R VALUE TEST SET COUNT : 2020 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 35.4896 - 5.7773 0.88 2026 143 0.2259 0.2900 REMARK 3 2 5.7773 - 4.5888 0.91 2011 150 0.1947 0.2880 REMARK 3 3 4.5888 - 4.0096 0.92 2054 144 0.1646 0.2414 REMARK 3 4 4.0096 - 3.6434 0.93 2018 142 0.1896 0.2363 REMARK 3 5 3.6434 - 3.3825 0.93 2038 143 0.1870 0.2522 REMARK 3 6 3.3825 - 3.1832 0.93 2018 145 0.2091 0.2547 REMARK 3 7 3.1832 - 3.0239 0.93 2006 141 0.2216 0.3119 REMARK 3 8 3.0239 - 2.8923 0.93 2047 147 0.2495 0.3335 REMARK 3 9 2.8923 - 2.7810 0.93 2010 141 0.2525 0.3118 REMARK 3 10 2.7810 - 2.6851 0.92 1995 147 0.2684 0.3016 REMARK 3 11 2.6851 - 2.6011 0.93 2054 141 0.2789 0.3313 REMARK 3 12 2.6011 - 2.5268 0.93 1979 142 0.2944 0.3486 REMARK 3 13 2.5268 - 2.4603 0.93 2049 145 0.3020 0.3851 REMARK 3 14 2.4603 - 2.4000 0.85 1799 128 0.3464 0.3962 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.72 REMARK 3 K_SOL : 0.39 REMARK 3 B_SOL : 44.96 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.760 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.21830 REMARK 3 B22 (A**2) : -18.96090 REMARK 3 B33 (A**2) : 26.17920 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.78980 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 6537 REMARK 3 ANGLE : 0.865 8868 REMARK 3 CHIRALITY : 0.060 925 REMARK 3 PLANARITY : 0.004 1155 REMARK 3 DIHEDRAL : 15.665 2379 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4F0E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072296. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-NOV-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 10.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93928 REMARK 200 MONOCHROMATOR : CHANNEL CUT ESRF MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30110 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.15900 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.46 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.69200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3BLJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40% 2-METHYL-1,3-PROPANEDIOL, 0.1 M REMARK 280 CAPS, 2MM STO1102, PH 10.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 22.69150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.53838 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -22.69150 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -123.38783 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 45.38300 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 457 REMARK 465 ALA A 656 REMARK 465 SER B 457 REMARK 465 MET B 458 REMARK 465 SER C 457 REMARK 465 MET C 458 REMARK 465 ALA C 557 REMARK 465 GLY C 558 REMARK 465 LYS C 559 REMARK 465 ASN C 560 REMARK 465 ALA C 561 REMARK 465 SER D 457 REMARK 465 MET D 458 REMARK 465 CYS D 556 REMARK 465 ALA D 557 REMARK 465 GLY D 558 REMARK 465 LYS D 559 REMARK 465 ASN D 560 REMARK 465 ALA D 561 REMARK 465 VAL D 562 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 458 CG SD CE REMARK 470 ARG A 633 CD NE CZ NH1 NH2 REMARK 470 ASN B 459 CG OD1 ND2 REMARK 470 ARG B 633 CD NE CZ NH1 NH2 REMARK 470 ASN C 459 CG OD1 ND2 REMARK 470 ASN C 617 CG OD1 ND2 REMARK 470 ASN C 620 CG OD1 ND2 REMARK 470 ARG C 633 CD NE CZ NH1 NH2 REMARK 470 ASN D 459 CG OD1 ND2 REMARK 470 ARG D 633 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 478 O HOH A 812 2.18 REMARK 500 O ASP C 626 O HOH C 811 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO D 479 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 460 128.67 -31.24 REMARK 500 ASN A 468 64.40 36.96 REMARK 500 HIS A 528 66.50 29.23 REMARK 500 ASN A 620 71.88 -118.38 REMARK 500 HIS B 528 57.58 34.68 REMARK 500 TYR B 582 -65.72 -94.36 REMARK 500 ASP B 586 -166.84 -72.56 REMARK 500 ASN B 620 79.21 -114.12 REMARK 500 LEU C 535 -164.44 -120.26 REMARK 500 LYS C 566 75.83 -106.51 REMARK 500 TYR C 582 -65.52 -91.86 REMARK 500 VAL C 611 -64.11 -107.23 REMARK 500 ASN C 620 60.84 -116.16 REMARK 500 PRO C 621 81.68 -63.56 REMARK 500 SER C 634 68.35 -156.48 REMARK 500 GLU C 649 -60.36 -109.99 REMARK 500 ASN D 526 -80.66 -77.40 REMARK 500 ASP D 527 -96.87 -137.99 REMARK 500 TYR D 582 -71.34 -98.99 REMARK 500 PRO D 621 43.36 -77.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP D 527 HIS D 528 138.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 0RU D 701 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0RU A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0RU C 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0RU D 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3BLJ RELATED DB: PDB REMARK 900 THE SAME PROTEIN WITHOUT LIGAND REMARK 900 RELATED ID: 3GEY RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH PJ-34 DBREF 4F0E A 459 656 UNP Q460N3 PAR15_HUMAN 459 656 DBREF 4F0E B 459 656 UNP Q460N3 PAR15_HUMAN 459 656 DBREF 4F0E C 459 656 UNP Q460N3 PAR15_HUMAN 459 656 DBREF 4F0E D 459 656 UNP Q460N3 PAR15_HUMAN 459 656 SEQADV 4F0E SER A 457 UNP Q460N3 EXPRESSION TAG SEQADV 4F0E MET A 458 UNP Q460N3 EXPRESSION TAG SEQADV 4F0E SER B 457 UNP Q460N3 EXPRESSION TAG SEQADV 4F0E MET B 458 UNP Q460N3 EXPRESSION TAG SEQADV 4F0E SER C 457 UNP Q460N3 EXPRESSION TAG SEQADV 4F0E MET C 458 UNP Q460N3 EXPRESSION TAG SEQADV 4F0E SER D 457 UNP Q460N3 EXPRESSION TAG SEQADV 4F0E MET D 458 UNP Q460N3 EXPRESSION TAG SEQRES 1 A 200 SER MET ASN LEU PRO GLU HIS TRP THR ASP MET ASN HIS SEQRES 2 A 200 GLN LEU PHE CYS MET VAL GLN LEU GLU PRO GLY GLN SER SEQRES 3 A 200 GLU TYR ASN THR ILE LYS ASP LYS PHE THR ARG THR CYS SEQRES 4 A 200 SER SER TYR ALA ILE GLU LYS ILE GLU ARG ILE GLN ASN SEQRES 5 A 200 ALA PHE LEU TRP GLN SER TYR GLN VAL LYS LYS ARG GLN SEQRES 6 A 200 MET ASP ILE LYS ASN ASP HIS LYS ASN ASN GLU ARG LEU SEQRES 7 A 200 LEU PHE HIS GLY THR ASP ALA ASP SER VAL PRO TYR VAL SEQRES 8 A 200 ASN GLN HIS GLY PHE ASN ARG SER CYS ALA GLY LYS ASN SEQRES 9 A 200 ALA VAL SER TYR GLY LYS GLY THR TYR PHE ALA VAL ASP SEQRES 10 A 200 ALA SER TYR SER ALA LYS ASP THR TYR SER LYS PRO ASP SEQRES 11 A 200 SER ASN GLY ARG LYS HIS MET TYR VAL VAL ARG VAL LEU SEQRES 12 A 200 THR GLY VAL PHE THR LYS GLY ARG ALA GLY LEU VAL THR SEQRES 13 A 200 PRO PRO PRO LYS ASN PRO HIS ASN PRO THR ASP LEU PHE SEQRES 14 A 200 ASP SER VAL THR ASN ASN THR ARG SER PRO LYS LEU PHE SEQRES 15 A 200 VAL VAL PHE PHE ASP ASN GLN ALA TYR PRO GLU TYR LEU SEQRES 16 A 200 ILE THR PHE THR ALA SEQRES 1 B 200 SER MET ASN LEU PRO GLU HIS TRP THR ASP MET ASN HIS SEQRES 2 B 200 GLN LEU PHE CYS MET VAL GLN LEU GLU PRO GLY GLN SER SEQRES 3 B 200 GLU TYR ASN THR ILE LYS ASP LYS PHE THR ARG THR CYS SEQRES 4 B 200 SER SER TYR ALA ILE GLU LYS ILE GLU ARG ILE GLN ASN SEQRES 5 B 200 ALA PHE LEU TRP GLN SER TYR GLN VAL LYS LYS ARG GLN SEQRES 6 B 200 MET ASP ILE LYS ASN ASP HIS LYS ASN ASN GLU ARG LEU SEQRES 7 B 200 LEU PHE HIS GLY THR ASP ALA ASP SER VAL PRO TYR VAL SEQRES 8 B 200 ASN GLN HIS GLY PHE ASN ARG SER CYS ALA GLY LYS ASN SEQRES 9 B 200 ALA VAL SER TYR GLY LYS GLY THR TYR PHE ALA VAL ASP SEQRES 10 B 200 ALA SER TYR SER ALA LYS ASP THR TYR SER LYS PRO ASP SEQRES 11 B 200 SER ASN GLY ARG LYS HIS MET TYR VAL VAL ARG VAL LEU SEQRES 12 B 200 THR GLY VAL PHE THR LYS GLY ARG ALA GLY LEU VAL THR SEQRES 13 B 200 PRO PRO PRO LYS ASN PRO HIS ASN PRO THR ASP LEU PHE SEQRES 14 B 200 ASP SER VAL THR ASN ASN THR ARG SER PRO LYS LEU PHE SEQRES 15 B 200 VAL VAL PHE PHE ASP ASN GLN ALA TYR PRO GLU TYR LEU SEQRES 16 B 200 ILE THR PHE THR ALA SEQRES 1 C 200 SER MET ASN LEU PRO GLU HIS TRP THR ASP MET ASN HIS SEQRES 2 C 200 GLN LEU PHE CYS MET VAL GLN LEU GLU PRO GLY GLN SER SEQRES 3 C 200 GLU TYR ASN THR ILE LYS ASP LYS PHE THR ARG THR CYS SEQRES 4 C 200 SER SER TYR ALA ILE GLU LYS ILE GLU ARG ILE GLN ASN SEQRES 5 C 200 ALA PHE LEU TRP GLN SER TYR GLN VAL LYS LYS ARG GLN SEQRES 6 C 200 MET ASP ILE LYS ASN ASP HIS LYS ASN ASN GLU ARG LEU SEQRES 7 C 200 LEU PHE HIS GLY THR ASP ALA ASP SER VAL PRO TYR VAL SEQRES 8 C 200 ASN GLN HIS GLY PHE ASN ARG SER CYS ALA GLY LYS ASN SEQRES 9 C 200 ALA VAL SER TYR GLY LYS GLY THR TYR PHE ALA VAL ASP SEQRES 10 C 200 ALA SER TYR SER ALA LYS ASP THR TYR SER LYS PRO ASP SEQRES 11 C 200 SER ASN GLY ARG LYS HIS MET TYR VAL VAL ARG VAL LEU SEQRES 12 C 200 THR GLY VAL PHE THR LYS GLY ARG ALA GLY LEU VAL THR SEQRES 13 C 200 PRO PRO PRO LYS ASN PRO HIS ASN PRO THR ASP LEU PHE SEQRES 14 C 200 ASP SER VAL THR ASN ASN THR ARG SER PRO LYS LEU PHE SEQRES 15 C 200 VAL VAL PHE PHE ASP ASN GLN ALA TYR PRO GLU TYR LEU SEQRES 16 C 200 ILE THR PHE THR ALA SEQRES 1 D 200 SER MET ASN LEU PRO GLU HIS TRP THR ASP MET ASN HIS SEQRES 2 D 200 GLN LEU PHE CYS MET VAL GLN LEU GLU PRO GLY GLN SER SEQRES 3 D 200 GLU TYR ASN THR ILE LYS ASP LYS PHE THR ARG THR CYS SEQRES 4 D 200 SER SER TYR ALA ILE GLU LYS ILE GLU ARG ILE GLN ASN SEQRES 5 D 200 ALA PHE LEU TRP GLN SER TYR GLN VAL LYS LYS ARG GLN SEQRES 6 D 200 MET ASP ILE LYS ASN ASP HIS LYS ASN ASN GLU ARG LEU SEQRES 7 D 200 LEU PHE HIS GLY THR ASP ALA ASP SER VAL PRO TYR VAL SEQRES 8 D 200 ASN GLN HIS GLY PHE ASN ARG SER CYS ALA GLY LYS ASN SEQRES 9 D 200 ALA VAL SER TYR GLY LYS GLY THR TYR PHE ALA VAL ASP SEQRES 10 D 200 ALA SER TYR SER ALA LYS ASP THR TYR SER LYS PRO ASP SEQRES 11 D 200 SER ASN GLY ARG LYS HIS MET TYR VAL VAL ARG VAL LEU SEQRES 12 D 200 THR GLY VAL PHE THR LYS GLY ARG ALA GLY LEU VAL THR SEQRES 13 D 200 PRO PRO PRO LYS ASN PRO HIS ASN PRO THR ASP LEU PHE SEQRES 14 D 200 ASP SER VAL THR ASN ASN THR ARG SER PRO LYS LEU PHE SEQRES 15 D 200 VAL VAL PHE PHE ASP ASN GLN ALA TYR PRO GLU TYR LEU SEQRES 16 D 200 ILE THR PHE THR ALA HET 0RU A 701 20 HET 0RU C 701 20 HET 0RU D 701 13 HETNAM 0RU 8-METHYL-2-[(PYRIMIDIN-2-YLSULFANYL)METHYL]QUINAZOLIN- HETNAM 2 0RU 4(1H)-ONE FORMUL 5 0RU 3(C14 H12 N4 O S) FORMUL 8 HOH *83(H2 O) HELIX 1 1 GLN A 481 CYS A 495 1 15 HELIX 2 2 ALA A 509 ASN A 526 1 18 HELIX 3 3 SER A 543 GLY A 551 1 9 HELIX 4 4 ASP A 573 ALA A 578 1 6 HELIX 5 5 GLN B 481 THR B 492 1 12 HELIX 6 6 ALA B 509 ASN B 526 1 18 HELIX 7 7 SER B 543 GLY B 551 1 9 HELIX 8 8 ASN B 553 ALA B 557 5 5 HELIX 9 9 ASP B 573 ALA B 578 1 6 HELIX 10 10 GLN C 481 CYS C 495 1 15 HELIX 11 11 ALA C 509 ASN C 526 1 18 HELIX 12 12 ASP C 540 ASP C 542 5 3 HELIX 13 13 SER C 543 GLY C 551 1 9 HELIX 14 14 ASP C 573 LYS C 579 1 7 HELIX 15 15 GLN D 481 THR D 492 1 12 HELIX 16 16 ALA D 509 ASN D 526 1 18 HELIX 17 17 SER D 543 GLY D 551 1 9 HELIX 18 18 ASP D 573 ALA D 578 1 6 SHEET 1 A 5 PHE A 472 GLN A 476 0 SHEET 2 A 5 ALA A 499 ASN A 508 -1 O GLN A 507 N CYS A 473 SHEET 3 A 5 ALA A 646 THR A 655 -1 O THR A 653 N GLU A 501 SHEET 4 A 5 LYS A 591 LEU A 599 -1 N MET A 593 O ILE A 652 SHEET 5 A 5 GLU A 532 THR A 539 -1 N ARG A 533 O VAL A 598 SHEET 1 B 4 THR A 568 ALA A 571 0 SHEET 2 B 4 LEU A 637 VAL A 640 -1 O PHE A 638 N PHE A 570 SHEET 3 B 4 SER A 627 THR A 629 -1 N VAL A 628 O VAL A 639 SHEET 4 B 4 PHE A 603 LYS A 605 1 N THR A 604 O THR A 629 SHEET 1 C 2 PRO A 615 ASN A 617 0 SHEET 2 C 2 ASN A 620 LEU A 624 -1 O ASP A 623 N LYS A 616 SHEET 1 D 5 PHE B 472 GLN B 476 0 SHEET 2 D 5 ALA B 499 ASN B 508 -1 O GLN B 507 N CYS B 473 SHEET 3 D 5 ALA B 646 THR B 655 -1 O GLU B 649 N ILE B 506 SHEET 4 D 5 LYS B 591 LEU B 599 -1 N LYS B 591 O PHE B 654 SHEET 5 D 5 GLU B 532 THR B 539 -1 N HIS B 537 O TYR B 594 SHEET 1 E 2 THR B 568 ALA B 571 0 SHEET 2 E 2 LEU B 637 VAL B 640 -1 O VAL B 640 N THR B 568 SHEET 1 F 2 PHE B 603 LYS B 605 0 SHEET 2 F 2 SER B 627 THR B 629 1 O THR B 629 N THR B 604 SHEET 1 G 5 PHE C 472 GLN C 476 0 SHEET 2 G 5 ALA C 499 ASN C 508 -1 O GLN C 507 N CYS C 473 SHEET 3 G 5 ALA C 646 THR C 655 -1 O THR C 655 N ALA C 499 SHEET 4 G 5 LYS C 591 LEU C 599 -1 N MET C 593 O ILE C 652 SHEET 5 G 5 GLU C 532 GLY C 538 -1 N ARG C 533 O VAL C 598 SHEET 1 H 4 THR C 568 ALA C 571 0 SHEET 2 H 4 LEU C 637 VAL C 640 -1 O PHE C 638 N PHE C 570 SHEET 3 H 4 SER C 627 THR C 629 -1 N VAL C 628 O VAL C 639 SHEET 4 H 4 PHE C 603 LYS C 605 1 N THR C 604 O THR C 629 SHEET 1 I 5 PHE D 472 GLN D 476 0 SHEET 2 I 5 ALA D 499 ASN D 508 -1 O ARG D 505 N VAL D 475 SHEET 3 I 5 ALA D 646 THR D 655 -1 O THR D 655 N ALA D 499 SHEET 4 I 5 LYS D 591 LEU D 599 -1 N ARG D 597 O TYR D 647 SHEET 5 I 5 GLU D 532 GLY D 538 -1 N LEU D 535 O VAL D 596 SHEET 1 J 2 THR D 568 ALA D 571 0 SHEET 2 J 2 LEU D 637 VAL D 640 -1 O VAL D 640 N THR D 568 SHEET 1 K 2 PHE D 603 LYS D 605 0 SHEET 2 K 2 SER D 627 THR D 629 1 O THR D 629 N THR D 604 SITE 1 AC1 10 HIS A 537 GLY A 538 ASP A 540 ASN A 560 SITE 2 AC1 10 TYR A 569 TYR A 576 SER A 577 THR A 581 SITE 3 AC1 10 TYR A 582 HOH A 827 SITE 1 AC2 11 PHE C 536 HIS C 537 GLY C 538 THR C 539 SITE 2 AC2 11 ASP C 540 TYR C 569 TYR C 576 SER C 577 SITE 3 AC2 11 THR C 581 TYR C 582 LEU C 637 SITE 1 AC3 7 HIS D 537 GLY D 538 TYR D 569 TYR D 576 SITE 2 AC3 7 SER D 577 TYR D 582 LEU D 637 CRYST1 69.676 45.383 123.389 90.00 90.25 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014352 0.000000 0.000062 0.00000 SCALE2 0.000000 0.022035 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008105 0.00000